Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype

Even the most advanced drug-eluting stents evoke unresolved issues, including chronic inflammation, late thrombosis, and neoatherosclerosis. This highlights the need for novel strategies that improve stent biocompatibility. Our studies show that apolipoprotein A-I (apoA-I) reduces in-stent restenosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanags, Laura Z., Tan, Joanne T.M., Galougahi, Keyvan K., Schaefer, Andreas, Wise, Steven G., Murphy, Andrew, Ali, Ziad A., Bursill, Christina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
PRECLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060078/
https://www.ncbi.nlm.nih.gov/pubmed/30062205
http://dx.doi.org/10.1016/j.jacbts.2017.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060078/
https://www.ncbi.nlm.nih.gov/pubmed/30062205
http://dx.doi.org/10.1016/j.jacbts.2017.11.006

Ejemplares similares